Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
20744 | 447 | 36.1 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
110 | 3 | PSYCHIATRY//SCHIZOPHRENIA//BIPOLAR DISORDER | 71389 |
617 | 2 | ANTIPSYCHOTICS//CLOZAPINE//SCHIZOPHRENIA | 13940 |
20744 | 1 | ASENAPINE//ZIPRASIDONE//LURASIDONE | 447 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ASENAPINE | authKW | 4568833 | 19% | 81% | 83 |
2 | ZIPRASIDONE | authKW | 2429541 | 25% | 31% | 113 |
3 | LURASIDONE | authKW | 1816730 | 11% | 53% | 50 |
4 | ILOPERIDONE | authKW | 1653104 | 7% | 73% | 33 |
5 | ZIPRASIDONE HYDROCHLORIDE | authKW | 213468 | 1% | 63% | 5 |
6 | MENTAL HLTH CSM | address | 136622 | 0% | 100% | 2 |
7 | LIFE QUAL STUDIES QUVI | address | 136618 | 1% | 50% | 4 |
8 | ANTIPSYCHOTIC SWITCH | authKW | 91080 | 0% | 67% | 2 |
9 | YMRS | authKW | 87825 | 1% | 43% | 3 |
10 | ANTIPSYCHOTICS | authKW | 74458 | 16% | 2% | 72 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Psychiatry | 8414 | 49% | 0% | 220 |
2 | Pharmacology & Pharmacy | 4098 | 55% | 0% | 248 |
3 | Clinical Neurology | 685 | 18% | 0% | 81 |
4 | Psychology, Clinical | 259 | 6% | 0% | 26 |
5 | Neurosciences | 232 | 15% | 0% | 69 |
6 | Biochemical Research Methods | 106 | 6% | 0% | 27 |
7 | Chemistry, Analytical | 99 | 8% | 0% | 35 |
8 | Chemistry, Medicinal | 28 | 3% | 0% | 14 |
9 | Behavioral Sciences | 10 | 2% | 0% | 7 |
10 | Medicine, General & Internal | 6 | 4% | 0% | 16 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MENTAL HLTH CSM | 136622 | 0% | 100% | 2 |
2 | LIFE QUAL STUDIES QUVI | 136618 | 1% | 50% | 4 |
3 | BORDERLINE PERSONAL DISORDER UNIT | 68311 | 0% | 100% | 1 |
4 | CBH HLTH | 68311 | 0% | 100% | 1 |
5 | CHILLD ADOLESCENT PSYCHIAT | 68311 | 0% | 100% | 1 |
6 | CLIN PHARMACOL NY | 68311 | 0% | 100% | 1 |
7 | CNS GLOBAL THER EUT TEAM | 68311 | 0% | 100% | 1 |
8 | CSM MALVARROSA | 68311 | 0% | 100% | 1 |
9 | DRUG IKEDA | 68311 | 0% | 100% | 1 |
10 | EARLY STAGE DEV PROC CHEM | 68311 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROPSYCHIATRIC DISEASE AND TREATMENT | 10102 | 3% | 1% | 15 |
2 | CNS SPECTRUMS | 7610 | 2% | 1% | 11 |
3 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 5663 | 3% | 1% | 15 |
4 | CNS DRUGS | 5620 | 3% | 1% | 12 |
5 | JOURNAL OF CLINICAL PSYCHIATRY | 5533 | 5% | 0% | 24 |
6 | PSYCHOPHARMAKOTHERAPIE | 4936 | 1% | 1% | 6 |
7 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 4487 | 2% | 1% | 11 |
8 | EXPERT OPINION ON DRUG SAFETY | 2364 | 1% | 1% | 6 |
9 | SCHIZOPHRENIA RESEARCH | 2274 | 3% | 0% | 14 |
10 | EXPERT OPINION ON PHARMACOTHERAPY | 1510 | 2% | 0% | 8 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ASENAPINE | 4568833 | 19% | 81% | 83 | Search ASENAPINE | Search ASENAPINE |
2 | ZIPRASIDONE | 2429541 | 25% | 31% | 113 | Search ZIPRASIDONE | Search ZIPRASIDONE |
3 | LURASIDONE | 1816730 | 11% | 53% | 50 | Search LURASIDONE | Search LURASIDONE |
4 | ILOPERIDONE | 1653104 | 7% | 73% | 33 | Search ILOPERIDONE | Search ILOPERIDONE |
5 | ZIPRASIDONE HYDROCHLORIDE | 213468 | 1% | 63% | 5 | Search ZIPRASIDONE+HYDROCHLORIDE | Search ZIPRASIDONE+HYDROCHLORIDE |
6 | ANTIPSYCHOTIC SWITCH | 91080 | 0% | 67% | 2 | Search ANTIPSYCHOTIC+SWITCH | Search ANTIPSYCHOTIC+SWITCH |
7 | YMRS | 87825 | 1% | 43% | 3 | Search YMRS | Search YMRS |
8 | ANTIPSYCHOTICS | 74458 | 16% | 2% | 72 | Search ANTIPSYCHOTICS | Search ANTIPSYCHOTICS |
9 | ATYPICAL ANTIPSYCHOTICS | 70990 | 8% | 3% | 37 | Search ATYPICAL+ANTIPSYCHOTICS | Search ATYPICAL+ANTIPSYCHOTICS |
10 | 13C6 N DESMETHYLASENAPINE | 68311 | 0% | 100% | 1 | Search 13C6+N+DESMETHYLASENAPINE | Search 13C6+N+DESMETHYLASENAPINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CITROME, L , (2014) ASENAPINE REVIEW, PART II: CLINICAL EFFICACY, SAFETY AND TOLERABILITY.EXPERT OPINION ON DRUG SAFETY. VOL. 13. ISSUE 6. P. 803 -830 | 46 | 84% | 10 |
2 | CITROME, L , (2013) A REVIEW OF THE PHARMACOLOGY, EFFICACY AND TOLERABILITY OF RECENTLY APPROVED AND UPCOMING ORAL ANTIPSYCHOTICS: AN EVIDENCE-BASED MEDICINE APPROACH.CNS DRUGS. VOL. 27. ISSUE 11. P. 879 -911 | 52 | 67% | 26 |
3 | MANDRIOLI, R , PROTTI, M , MERCOLINI, L , (2015) EVALUATION OF THE PHARMACOKINETICS, SAFETY AND CLINICAL EFFICACY OF ZIPRASIDONE FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 11. ISSUE 1. P. 149 -174 | 66 | 39% | 1 |
4 | PLOSKER, GL , DEEKS, ED , (2016) ASENAPINE: A REVIEW IN SCHIZOPHRENIA.CNS DRUGS. VOL. 30. ISSUE 7. P. 655 -666 | 36 | 69% | 0 |
5 | CITROME, L , (2012) ORAL ANTIPSYCHOTIC UPDATE: A BRIEF REVIEW OF NEW AND INVESTIGATIONAL AGENTS FOR THE TREATMENT OF SCHIZOPHRENIA.CNS SPECTRUMS. VOL. 17. ISSUE . P. 1 -9 | 27 | 84% | 2 |
6 | TARAZI, FI , STAHL, SM , (2012) ILOPERIDONE, ASENAPINE AND LURASIDONE: A PRIMER ON THEIR CURRENT STATUS.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 13. ISSUE 13. P. 1911 -1922 | 35 | 61% | 9 |
7 | WANG, SM , HAN, C , LEE, SJ , PATKAR, AA , MASAND, PS , PAE, CU , (2013) ASENAPINE, BLONANSERIN, ILOPERIDONE, LURASIDONE, AND SERTINDOLE: DISTINCTIVE CLINICAL CHARACTERISTICS OF 5 NOVEL ATYPICAL ANTIPSYCHOTICS.CLINICAL NEUROPHARMACOLOGY. VOL. 36. ISSUE 6. P. 223-238 | 39 | 47% | 5 |
8 | CITROME, L , (2014) ASENAPINE REVIEW, PART I: CHEMISTRY, RECEPTOR AFFINITY PROFILE, PHARMACOKINETICS AND METABOLISM.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 10. ISSUE 6. P. 893-903 | 23 | 74% | 4 |
9 | SCHEIDEMANTEL, T , KOROBKOVA, I , REJ, S , SAJATOVIC, M , (2015) ASENAPINE FOR BIPOLAR DISORDER.NEUROPSYCHIATRIC DISEASE AND TREATMENT. VOL. 11. ISSUE . P. 3007 -3017 | 24 | 60% | 1 |
10 | MARAZZITI, D , PICCINNI, A , BARONI, S , MUNGAI, F , PRESTA, S , MUCCI, F , DELL'OSSO, L , (2016) CURRENT TRENDS ON ANTIPSYCHOTICS: FOCUS ON ASENAPINE.CURRENT MEDICINAL CHEMISTRY. VOL. 23. ISSUE 21. P. 2204 -2216 | 29 | 49% | 0 |
Classes with closest relation at Level 1 |